• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pamidronate versus zoledronic acid for the treatment of multiple myeloma-related hypercalcemia.

作者信息

Shulman Rachel, Geara Abdallah S, Berns Jeffrey S

机构信息

Renal Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Renal Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Kidney Int. 2022 May;101(5):1086. doi: 10.1016/j.kint.2021.12.033.

DOI:10.1016/j.kint.2021.12.033
PMID:35461601
Abstract
摘要

相似文献

1
Pamidronate versus zoledronic acid for the treatment of multiple myeloma-related hypercalcemia.帕米膦酸与唑来膦酸治疗多发性骨髓瘤相关高钙血症的比较
Kidney Int. 2022 May;101(5):1086. doi: 10.1016/j.kint.2021.12.033.
2
The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy.使用唑来膦酸，一种新型、高效的双膦酸盐，用于治疗恶性肿瘤引起的高钙血症。
Oncologist. 2002;7(6):481-91. doi: 10.1634/theoncologist.7-6-481.
3
Advances in the biology and treatment of myeloma bone disease.骨髓瘤骨病的生物学与治疗进展
Am J Health Syst Pharm. 2001 Nov 15;58 Suppl 3:S16-20. doi: 10.1093/ajhp/58.suppl_3.S16.
4
Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.唑来膦酸与帕米膦酸二钠治疗晚期多发性骨髓瘤或乳腺癌患者骨骼并发症的长期疗效及安全性：一项随机、双盲、多中心、对照试验。
Cancer. 2003 Oct 15;98(8):1735-44. doi: 10.1002/cncr.11701.
5
Comparative effectiveness on survival of zoledronic acid versus pamidronate in multiple myeloma.唑来膦酸与帕米膦酸对多发性骨髓瘤患者生存的比较疗效
Leuk Lymphoma. 2015 Mar;56(3):615-21. doi: 10.3109/10428194.2014.924117. Epub 2014 Jul 14.
6
Potential effect of zoledronate therapy in heavy proteinuria.唑来膦酸治疗对重度蛋白尿的潜在影响。
Clin Nephrol. 2007 Apr;67(4):263-5. doi: 10.5414/cnp67263.
7
Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program.唑来膦酸治疗恶性肿瘤高钙血症：国际临床开发项目的结果
Semin Oncol. 2001 Apr;28(2 Suppl 6):17-24. doi: 10.1016/s0093-7754(01)90261-1.
8
Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).帕米膦酸二钠和唑来膦酸在多发性骨髓瘤患者中的安全性和疗效比较评估（单中心经验）
Acta Pol Pharm. 2002 Nov-Dec;59(6):478-82.
9
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.唑来膦酸在治疗恶性肿瘤高钙血症方面优于帕米膦酸：两项随机对照临床试验的汇总分析。
J Clin Oncol. 2001 Jan 15;19(2):558-67. doi: 10.1200/JCO.2001.19.2.558.
10
Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.帕米膦酸二钠治疗一名血液透析患者的严重高钙血症
Nat Clin Pract Nephrol. 2006 Aug;2(8):459-63; quiz 464. doi: 10.1038/ncpneph0248.